2025 Merkin Prize in Biomedical Technology awarded to pioneers of CAR T-cell therapy
Broad Institute
MAY 21, 2025
Merkin Prize in Biomedical Technology for developing chimeric antigen receptor (CAR) T-cell therapy, a groundbreaking form of personalized cancer immunotherapy that turns T cells into tumor killers and has led to durable remissions in tens of thousands of patients with previously incurable blood cancers.
Let's personalize your content